SASCRO Statement on SBRT for Oligo-Metastatic Prostate Cancer

A request was made by a medical scheme to SASCRO on 14 January 2019 for comments on the role of

Reports by the International Commission on Radiation units and measurements including the ICRU 83

The ICRU 83 provides the information necessary to standardize techniques and procedures and to harmonize the prescribing, recording and reporting

Management of Unscheduled Treatment Interruptions

The timely delivery of radical radiotherapy: Standards and guidelines for the management of unscheduled treatment interruptions.   Download

SASCRO Statement on IMRT or VMAT

IMRT (Intensity Modulated Radiation Therapy) is considered a standard of care in the treatment of many types cancer in South

SASCRO Statement on Prostate Radioactive Ligand Therapy

Prostate Radioactive Ligand Therapy should not be administered to patients outside ethically approved and formal clinical trials.   Download

SASCRO Statement on IORT

The aim of lumpectomy and post-operative irradiation for selected patient with early breast cancer is preservation of the breast while

SASCRO Prostate Brachytherapy Guidelines Task Group

These guidelines are a tool to assist medical practitioners in providing evidence based care for patients receiving prostate brachytherapy. They

Quantitative Analysis of Normal Tissue Effects

The Quantitative Analysis of normal tissue effects in the clinic review summarized the currently available 3D dose/volume/outcome data to update

Stereotactic Ablative Body Radiotherapy

This document, endorsed by the Faculty of Clinical Oncology of The Royal College of Radiologists, intends to provide guidance on

Consent to Medical Treatment in South Africa: A Medical Protection Guide

A guide compiled by the Medical Protection Society of SA on the consent process for medical treatment. The first point